News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,036 Results
Type
Article (28)
Press Release (3008)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (1)
Alliances (42)
Alzheimer's disease (28)
Approvals (106)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (5)
Cancer (51)
Career advice (1)
Clinical research (626)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (64)
Diabetes (1)
Diagnostics (21)
Drug discovery (1)
Drug pricing (1)
Earnings (1414)
Events (324)
FDA (121)
Frontotemporal dementia (1)
Funding (3)
Generative AI (1)
Gene therapy (4)
GLP-1 (7)
Government (9)
Guidances (2)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (160)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (23)
Lymphoma (6)
Manufacturing (1)
MASH (3)
Medical device (56)
Medtech (56)
Mergers & acquisitions (23)
Metabolic disorders (5)
Multiple sclerosis (2)
NASH (1)
Neuroscience (34)
NextGen: Class of 2025 (9)
Non-profit (4)
Northern California (32)
Obesity (1)
Opinion (1)
Parkinson's disease (1)
Peanut (1)
People (8)
Phase I (94)
Phase II (190)
Phase III (370)
Pipeline (45)
Policy (1)
Postmarket research (27)
Preclinical (12)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (5)
Regulatory (140)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (1)
Schizophrenia (2)
Southern California (14)
Startups (3)
United States (255)
Vaccines (3)
Date
Today (1)
Last 7 days (2)
Last 30 days (27)
Last 365 days (428)
2025 (119)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (332)
Australia (13)
California (50)
Canada (15)
China (9)
Connecticut (1)
Delaware (14)
Europe (600)
Florida (8)
Georgia (2)
Illinois (6)
Indiana (16)
Japan (8)
Maryland (11)
Massachusetts (35)
Minnesota (1)
New Jersey (45)
New York (26)
North Carolina (9)
Northern California (32)
Ohio (2)
Pennsylvania (18)
South America (5)
Southern California (14)
Texas (8)
Utah (5)
Washington State (3)
3,036 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial
March 31, 2025
·
7 min read
Press Releases
Topline Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in Patients with Early Alzheimer’s Disease Carrying Two Copies of APOE4 Gene
April 10, 2025
·
13 min read
Press Releases
Alvotech Reports Record Results for 2024 and Provides Business Update
March 27, 2025
·
27 min read
Press Releases
XORTX Announces Update for Discussion with the FDA
March 19, 2025
·
8 min read
Press Releases
Innovent Announces 2024 Annual Results and Business Updates
March 27, 2025
·
8 min read
Press Releases
Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 6, 2025
·
15 min read
Press Releases
New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings
March 26, 2025
·
19 min read
Press Releases
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
March 20, 2025
·
13 min read
Press Releases
European Commission approves subcutaneous RYBREVANT®▼ (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
April 8, 2025
·
17 min read
Press Releases
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
February 25, 2025
·
26 min read
1 of 304
Next
